1 / 6

FDA/PhUSE WG 5

WG5 aims to develop validated scripts for advanced analysis techniques, establish a non-fee platform for script housing, and promote script sharing among industry experts. Objectives include creating a script library, improving contributed scripts, and defining analysis standards. The group also focuses on data transformation specifications, script registration processes, and leveraging CDISC standards for successful script execution. With a glossary of analysis terms and test data support, WG5 enhances script validation and contributes to a streamlined review process.

freddieg
Download Presentation

FDA/PhUSE WG 5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA/PhUSE WG 5 Development of Standard Scripts for Analysis & Programming Goals and Objectives

  2. Goals and Objectives • Developed by WG leadership team • Posted on WG 5 Wiki: http://www.phusewiki.org/wiki/index.php?title=WG5_Charter • Provide a starting point and focus for March F2F sessions.

  3. Goals • Support development of validated scripts • Enable use of cutting edge analysis techniques within the review environment • Develop technical requirements for a non-fee based platform that houses the scripts • Share approaches for analysis of clinical trials safety data to develop a core set of analyses for characterization of compound safety profiles.

  4. Objectives • Develop a platform for sharing scripts that will • Support development of script library that leverages industry data standards. • Encourage script contributions from the pharmaceutical community, regulators and academics. • Encourage ongoing improvement of contributed scripts. • Provide documentation with sufficient detail that consumers know how and when to use the script. • Support a library search capability. • Develop metadata for contributed programs. • Develop standards for specifying analysis. Network with subject matter experts to develop a list of core tables figures and listings applicable across compounds.

  5. Objectives • Develop standards for specification of data transforms. • Develop a process for registering, managing, testing and publishing scripts. • Leverage existing CDISC SDTM and ADaM standards. • Identify validation rules for ADaM datasets that would support successful execution of scripts. • Develop a glossary of analysis terminology. • Develop recommendations for a process that validates scripts. • Provide test data to support validation of scripts. • Contribute to the review and approval process by filling gaps while avoiding duplication of effort.

  6. WG5 – Subgroups… • What scripts do we want/need? • Creation and validation of scripts • Platform for script management

More Related